EMEA-000156-PIP01-07-M02
Key facts
| Active substance |
Antigen of pre-pandemic strain A/Vietnam/1203/2004 propagated in Vero cells
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/67/2011
|
| PIP number |
EMEA-000156-PIP01-07-M02
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Influenza infection caused by an influenza strain contained in the vaccine or related to a strain contained in the vaccine
|
| Route(s) of administration |
Intramuscular injection
|
| Contact for public enquiries |
Baxter Innovations GmbH
E-mail: johannes_braun@baxter.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000156-PIP01-07-M02
|
| Compliance opinion date |
17/01/2013
|
| Compliance outcome |
positive
|